|
|
|
|
| LEADER |
01071cam a2200313 4500 |
| 001 |
PPN010279679 |
| 005 |
20161222112800.0 |
| 010 |
|
|
|a 0-89004-639-5
|
| 035 |
|
|
|a sib1170050
|
| 100 |
|
|
|a 19980210d1982 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a US
|
| 105 |
|
|
|a a z 001yy
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a The benzamides
|b Texte imprimé
|e pharmacology, neurobiology, and clinical aspects
|f editors, Michael Stanley, John Rotrosen
|
| 210 |
|
|
|a New York
|c Raven Press
|d cop. 1982
|
| 215 |
|
|
|a 1 vol. (XII-209 p.)
|c ill.
|d 27 cm
|
| 225 |
1 |
|
|a Advances in biochemical psychopharmacology
|v 35
|
| 320 |
|
|
|a Notes bibliogr. Index
|
| 410 |
|
| |
|0 01341061X
|t Advances in biochemical psychopharmacology
|x 0065-2229
|v 35
|
| 606 |
|
|
|3 PPN040669599
|a Benzamides
|2 fmesh
|
| 606 |
|
|
|3 PPN031499562
|a Benzamide
|2 rameau
|
| 702 |
|
1 |
|3 PPN032265204
|a Stanley
|b Michael
|4 340
|
| 702 |
|
1 |
|3 PPN032265220
|a Rotrosen
|b John
|4 340
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20080519
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
| 930 |
|
|
|5 441092101:336033850
|b 441092101
|a 55018
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 302556
|
Nantilus
